Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan
· Delayed Price · Currency is TWD 15.50
-0.75 (-4.62%)
Mar 10, 2026, 1:56 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.43 billion as of March 9, 2026. Its market cap has decreased by -28.10% in one year.
Market Cap
1.43B
Enterprise Value
2.44B
Revenue
486.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.50
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.43B, a decrease of -26.54%. That is a compound annual growth rate of -10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.43B | -0.61% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.47B |
| Great Novel Therapeutics Biotech & Medicals | 1.42B |
| NeoCore Technology | 1.50B |
| GenMont Biotech Incorporation | 1.54B |
| Enimmune | 1.27B |
| Genomics BioSci & Tech. | 1.75B |
| GeneReach Biotechnology | 1.17B |
| Advagene Biopharma | 1.83B |